News

Actualité

American Diabetes Association

Physiogenex will be participating at the American Diabetes Association 68th session, San Francisco, CA - USA, June 6 - 10, 2008

Read more

Improved safety and efficacy considerations on cardiovascular aspects do not necessarily be translated in longer pre-clinical studies but could also represent a real competitive advantage

June 28, 29, 2008, The Wall Street journal: “The FDA is weighting whether to insist that new diabetes drugs have a positive impact on cardio-vascular disease and life span which are more difficult to measure than current benchmarks such as blood sugar…no drug that regulates sugar levels has yet shown beneficial cardiac effects in Type 2 diabetics”.

Read more

Catalogue

Hypercholesterolemic hamster model

An original hamster nutritional model dedicated to mimic human hypercholesterolemia and specifically designed to cholesterol and lipoproteins studies.

Read more

A Race for Life

Physiogenex is a proud sponsor of the 2008 London Marathon.

Read more